Navigation Links
Lightlake Therapeutics Inc. to Apply Company's Patented Technology in the Development of Premenstrual Syndrome Overeating Treatment
Date:1/6/2012

nts who are obese or overweight as a result of Binge Eating Disorder in addition to those patients suffering from Bulimia Nervosa. Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of these purposes in the future.

Safe Harbor

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors. These and other factors may cause our actual results to differ materially from any forward- looking statement. We undertake no obligation to update any of the forward-looking statements after the date of this presentation to conform those statements to reflect the occurrence of unanticipated events, except as required by applicable law.

Investor Contact:
Mr. Kevin Fickle, President
NUWA Group LLC.
Tel: +1-925-330-8315
Email: '/>"/>

SOURCE Lightlake Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland
2. Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003
3. Orexigen Therapeutics to Present at the J.P. Morgan Healthcare Conference
4. Halo Therapeutics HT-100 Receives FDAs Orphan Designation for Duchenne Muscular Dystrophy
5. Echo Therapeutics Announces $3.6 Million Warrant Exercises
6. Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco
7. Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock
8. AuraSense Therapeutics Secures Series B Equity Investment
9. PTC Therapeutics Antibacterial Program Receives $5 Million Award from the Wellcome Trust
10. Arecor Forms Collaboration With Lilly to Develop Advanced Formulations of Protein Therapeutics
11. Cerevast Therapeutics Receives CE Mark for Clotbust ER™ Ultrasound Stroke Treatment Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2013 through 2020. Also, a ...
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report ... Animals. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:9/16/2014)... , Sept. 16, 2014  ROX Medical ... an international multi-center, prospective, randomized, controlled, blinded endpoint ... of arterial hypertension. The CONTROL-HTN trial, NCT01642498, evaluated the ... a fixed connection between a central artery and ... treatment of hypertension. The primary outcomes are reduction ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11
(Date:9/16/2014)... (PRWEB) September 16, 2014 Paradigm Physical ... offering a new therapeutic treatment for their patients. Dry ... to treat a variety of musculoskeletal problems. , In ... is inserted into the skin and muscle to create ... the needle, the needle helps to deactivate and release ...
(Date:9/16/2014)... These new programs allow those who haven’t owned ... to $10,000 in a 0% interest free, 2nd down payment ... and federal programs, are listed on their private website. The ... sell or move out of the property. The down payment ... are no monthly payments paid by the Borrower. The money ...
(Date:9/16/2014)... 16, 2014 (HealthDay News) -- Although magnesium sulfate is ... preterm delivery, new research suggests it won,t provide any ... effects of magnesium sulfate given to pregnant women, researchers ... behavioral, growth or functional outcomes among those children when ... old. The new findings don,t negate the fact ...
(Date:9/16/2014)... with prostate cancer may one day be able to ... their urinary and sexual functioning, thanks in part to ... presented at the American Society for Radiation Oncology,s 56th ... data gathered from more than 17,000 surveys completed by ... when patients, urinary and sexual symptoms changed following each ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 This year’s ... GREEN and Sustainable company Glen Mills, Pennsylvania, September 15, ... and one of the fastest growing companies in the ... turf, flower, shrub, and tree health-care by naturally decreasing ... wall development. Today it announced that it will hold ...
Breaking Medicine News(10 mins):Health News:Paradigm Physical Therapy Introduces Dry Needling 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 3Health News:Researchers Don't See Long-Term Benefits From Drug for Preemies 2Health News:Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning 2Health News:Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning 3Health News:Holganix Holds 3rd Annual Bionutritional Summit in Louisville, Kentucky 2
... ... Employers in the United States have become less satisfied with their ... Institute. Hit hard by the recession, employers of all ... the value they derive from it. They are looking to their ...
... ... southeast such as credit and debit card payment processing, electronic check conversion and ... need of a payment acceptance solution, or a potential sales representative looking for ... allows for convenient access to the right tools. , ...
... ... problem set for anesthesiologists to solve. Patients must wake up quickly and able to go home ... set a higher standard of care for patient safety in outpatient surgery,” says Dr. F. Don ... ...
... , , SEATTLE , Jan. 19 ... of the Haiti earthquake, aid workers also must address ... , relief director for Christian humanitarian organization, World Vision, debunks five ... clothing is a cost-effective way to help , The cost ...
... , , President & CEO ... , WASHINGTON , Jan. 18 Outside the damaged ... Haiti and around the world are working side-by-side to clean and ... the neighborhood camps today, providing basic relief items, such as tarps, blankets, ...
... of the resorbable material polydioxanone appears to facilitate corrective ... the two airways, according to a report in the ... , one of the JAMA/Archives journals. Conventional septoplasty, ... always possible because the surgical manipulations involved weaken the ...
Cached Medicine News:Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 2Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 3Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 4Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 5Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 6Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 7Health News:TBT Payment Acceptance Solutions Announces Launch of Redesigned “User-Friendly” Website, www.tbtpas.com 2Health News:Michael Jackson Propofol Expert, Barry Friedberg MD, Spoke at Pan Pacific Surgery Meeting 2Health News:Myths of Disaster Relief 2Health News:Myths of Disaster Relief 3Health News:American Red Cross Provides First Aid, Supplies in Croix Deprez 2Health News:American Red Cross Provides First Aid, Supplies in Croix Deprez 3Health News:Synthetic, dissolving plates ease repairs of nasal septum defects 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: